Cresset Asset Management LLC Cuts Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Cresset Asset Management LLC decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 89.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,548 shares of the company's stock after selling 12,778 shares during the period. Cresset Asset Management LLC's holdings in HCA Healthcare were worth $465,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Whipplewood Advisors LLC purchased a new position in HCA Healthcare in the fourth quarter worth $31,000. Tidemark LLC purchased a new position in HCA Healthcare in the fourth quarter worth $36,000. Activest Wealth Management boosted its position in HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after purchasing an additional 125 shares during the last quarter. Pinnacle Bancorp Inc. boosted its position in HCA Healthcare by 50.0% in the fourth quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock worth $45,000 after purchasing an additional 50 shares during the last quarter. Finally, Legacy Investment Solutions LLC raised its stake in shares of HCA Healthcare by 99.0% in the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company's stock valued at $62,000 after buying an additional 95 shares during the period. Hedge funds and other institutional investors own 62.73% of the company's stock.

Analyst Upgrades and Downgrades

HCA has been the topic of several research reports. Robert W. Baird restated a "neutral" rating and issued a $336.00 target price (down from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Baird R W lowered HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Barclays lowered their target price on HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating on the stock in a research note on Monday, January 27th. Guggenheim assumed coverage on HCA Healthcare in a research note on Wednesday, April 9th. They set a "neutral" rating on the stock. Finally, Royal Bank of Canada decreased their price objective on HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating on the stock in a research note on Monday, April 28th. One analyst has rated the stock with a sell rating, six have given a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $381.13.

HCA Healthcare Price Performance

HCA opened at $366.98 on Thursday. The stock has a 50-day moving average price of $338.45 and a 200-day moving average price of $328.35. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The stock has a market capitalization of $88.29 billion, a P/E ratio of 16.70, a PEG ratio of 1.10 and a beta of 1.46.

HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $5.75 by $0.70. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The firm had revenue of $18.32 billion during the quarter, compared to analysts' expectations of $18.26 billion. During the same period in the prior year, the business earned $5.36 EPS. The company's revenue for the quarter was up 5.7% compared to the same quarter last year. Equities analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.78%. The ex-dividend date is Monday, June 16th. HCA Healthcare's dividend payout ratio is presently 12.81%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the company's stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the transaction, the senior vice president now owns 15,412 shares of the company's stock, valued at $4,971,757.08. This represents a 38.22% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.